CLINICAL RESEARCH: HEART RHYTHM DISORDER
Three-Dimensional Electroanatomical Voltage Mapping and Histologic Evaluation of Myocardial Substrate in Right Ventricular Outflow Tract Tachycardia
Domenico Corrado, MD, PhD*,*,
Cristina Basso, MD, PhD ,
Loira Leoni, MD, PhD*,
Barbara Tokajuk, MD, PhD*,
Pietro Turrini, MD, PhD*,
Barbara Bauce, MD, PhD*,
Federico Migliore, MD*,
Andrea Pavei, MD*,
Giuseppe Tarantini, MD, PhD*,
Massimo Napodano, MD*,
Angelo Ramondo, MD*,
Gianfranco Buja, MD*,
Sabino Iliceto, MD* and
Gaetano Thiene, MD
* Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua Medical School, Padua, Italy
Department of Medical-Diagnostic Sciences, University of Padua Medical School, Padua, Italy.
Manuscript received June 11, 2007;
revised manuscript received October 24, 2007,
accepted November 8, 2007.
* Reprint requests and correspondence: Dr. Domenico Corrado, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Via Giustiniani, 2-35121 Padova, Italy. (Email: domenico.corrado{at}unipd.it).
Objectives: We tested whether 3-dimensional electroanatomical voltage mapping (EVM) may help in the differential diagnosis between idiopathic right ventricular outflow tract (RVOT) tachycardia and arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).
Background: Right ventricular EVM has been demonstrated to reliably identify low-voltage regions ("electroanatomical scar"), which in patients with ARVC/D correspond to areas of fibrofatty myocardial replacement.
Methods: The study population comprised 27 patients (15 men and 12 women, age 33.9 ± 8 years) with RVOT tachycardia and no echocardiographic/angiographic evidence of right ventricular (RV) dilation/dysfunction, who underwent EVM and endomyocardial biopsy (EMB) for characterization of ventricular tachycardia (VT) substrate before catheter ablation.
Results: Electroanatomical voltage mapping was normal in 20 of 27 patients (74%, group A), with electrogram voltage >1.5 mV throughout the RV. The other 7 patients (26%, group B) showed 1 (1.4 ± 07) RV electroanatomical scar area(s) (bipolar voltage <0.5 mV) that correlated with fibrofatty myocardial replacement at EMB (p < 0.001). Clinical predictors of RV scar were right precordial QRS prolongation (p < 0.001) and VT inducibility (p = 0.001). Catheter ablation successfully eliminated VT in 18 of 20 patients (90%). During a follow-up of 41 ± 8 months, 3 of 7 patients (43%) from group B received an implantable defibrillator because of life-threatening ventricular arrhythmias, compared with no patients from group A (p = 0.016).
Conclusions: An early/minor form of ARVC/D may mimic idiopathic RVOT tachycardia. Electroanatomical voltage mapping is able to identify RVOT tachycardia due to concealed ARVC/D by detecting RVOT electroanatomical scars that correlate with fibrofatty myocardial replacement at EMB and predispose to sudden arrhythmic death.
|
Abbreviations and Acronyms
| | ARVC/D = arrhythmogenic right ventricular cardiomyopathy/dysplasia | | CMR = cardiac magnetic resonance | | EMB = endomyocardial biopsy | | EVM = electroanatomical voltage mapping | | LV = left ventricle/ventricular | | RV = right ventricle/ventricular | | RVOT = right ventricular outflow tract | | SAECG = signal-averaged electrocardiogram | | VT = ventricular tachycardia |
|
Related Articles
-
Diagnosing Subtle Forms of Potentially Life-Threatening Diseases
- David J. Callans
J. Am. Coll. Cardiol. 2008 51: 740-741.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A35-A36.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
B. Thomas and N. J. Tavares
The right ventricular outflow tract in arrhythmogenic right ventricular cardiomyopathy.
J. Am. Coll. Cardiol.,
October 13, 2009;
54(16):
1558 - 1559.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al.
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
Europace,
June 1, 2009;
11(6):
771 - 817.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Corrado, C. Basso, and G. Thiene
Arrhythmogenic right ventricular cardiomyopathy: an update
Heart,
May 1, 2009;
95(9):
766 - 773.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Corrado, C. Basso, A. Pelliccia, and G. Thiene
CHAPTER 32 Sports and Heart Disease
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Basso, F. Ronco, F. Marcus, A. Abudureheman, S. Rizzo, A. C. Frigo, B. Bauce, F. Maddalena, A. Nava, D. Corrado, et al.
Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria
Eur. Heart J.,
November 2, 2008;
29(22):
2760 - 2771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Cooper Jr
Right from the heart: when should myocardial biopsy be performed for suspected arrhythmogenic right ventricular cardiomyopathy/dysplasia?
Eur. Heart J.,
November 2, 2008;
29(22):
2705 - 2707.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Callans
Diagnosing Subtle Forms of Potentially Life-Threatening Diseases.
J. Am. Coll. Cardiol.,
February 19, 2008;
51(7):
740 - 741.
[Full Text]
[PDF]
|
 |
|
|